The Administration issued Executive Order (“EO”) 14293: Regulatory Relief to Promote Domestic Production of Critical Medicines on May 5, 2025 (whitehouse.gov ...
LONDON/COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk has laid off dozens of employees at the largest U.S. manufacturing site for its blockbuster obesity and diabetes drugs, a Reuters review of ...
Climate change-driven extreme weather events threaten the US pharmaceutical supply chain, with 62.8% of facilities in disaster-prone counties. Hurricane Helene in 2024 highlighted the vulnerability of ...
As the U.S. focuses on beefing up its biopharma manufacturing infrastructure this year, a similar effort toward improved drug shortage resilience has been playing out across the pond. Now, following a ...
The demand for the widely used cancer drug Taxol is increasing, but it's difficult and expensive to produce because it hasn't been possible to do it biosynthetically. Until now, that is. Researchers ...
Hosted on MSN
Factbox-weight-loss drug developers line up to tap lucrative market as competition heats up
Dec 12 (Reuters) - The weight-loss drug market is booming, with biotech firms racing to secure their place in a lucrative sector currently dominated by Novo Nordisk and Eli Lilly. Analysts project the ...
Adial Pharmaceuticals signs agreements with Cambrex and Thermo Fisher for AD04 drug production and NDA submission for Alcohol Use Disorder. Adial Pharmaceuticals, Inc. has announced the execution of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback